Lower extremity weakness as the first sign of an abdominal aortic aneurysm

Autor: Caleb Baz Figueroa, MD, Alejandro Delgado Molinos, MD, Octavio de la Torre Scherak, MD, Ángel López Castillo, MD, Juan Carlos Moy Petersen, MD, Francisco José Farrais Expósito, MD, Jose Carlos Cruz Arteaga, MD, Raúl Portas Gómez, MD, Jose Antonio Pérez Gómez, MD

Publikováno v: Journal of Vascular Surgery Cases and Innovative Techniques, Vol 6, Iss 2, Pp 221-223 (2020)

Giant aortic aneurysms are rare entities with a high mortality, and only a few cases have been described. Spinal cord ischemia secondary to an aortic aneurysm occurs even more rarely. We present the case of a giant aneurysm of the infrarenal abdomina

Externí odkaz: https://doaj.org/article/bf166d0eabd944958050583daa0d8a4e

Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results

Autor: Sham Mailankody, Jeffrey V. Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Olalekan O. Oluwole, Shahbaz Malik, Rajneesh Nath, Faiz Anwer, Jose Carlos Cruz, Myo Htut, Erin E. Karski, Wade Lovelace, Myles Dillon, Eric Butz, Wendy Ying, Arun Balakumaran, Shaji K. Kumar

Publikováno v: Nature Medicine.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70d4720d352f99a57658783b7fa238d2
https://doi.org/10.1038/s41591-023-02306-7

Preliminary Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)

Autor: Keith Pratz, Mohamad Cherry, Jessica K. Altman, Brenda W. Cooper, Jose Carlos Cruz, Joseph G. Jurcic, Mark J. Levis, Tara L. Lin, Alexander E. Perl, Nikolai A. Podoltsev, Gary J. Schiller, Chaofeng Liu, Erkut Bahceci

Publikováno v: Blood. 130:722-722

Background: Gilteritinib is a novel, potent, highly-selective oral fms -like tyrosine kinase 3 (FLT3)/AXL inhibitor with clinical activity in relapsed/refractory (R/R) AML with activating FLT3-ITD and -TKD mutations. In such patients, once-daily gilt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f3a22845b6723210cd0b8b6ffe75957e
https://doi.org/10.1182/blood.v130.suppl_1.722.722

[Radiotherapy for pancreatic cancer]

Autor: Eduardo, Weltman, Joao Victor, Salvajoli, Rodrigo de Morais, Hanriot, Flavio Eduardo, Prisco, Satiro Nakamura de, Oliveira, Jose Carlos, Cruz, Sandra Regina de Oliveira, Borges, Monica, Lagatta, Dalia Ballas, Wajsbrot

Publikováno v: Revista da Associacao Medica Brasileira (1992). 48(2)

The pancreatic adenocarcinoma is an aggressive disease for which cure is only possible in less than 20% of the best cases. Adjuvant radiotherapy and chemotherapy so far have improved symptoms with little, but significant, increase in survival rates.R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7a9c0255eda3c7850869049ba17a9905
https://pubmed.ncbi.nlm.nih.gov/12205528

Selection of efficient rhizobial symbionts for Cratylia argentea in the cerrado biome

Autor: Giovanna Moura Calazans, José Carlos Cruz, Christiane Abreu de Oliveira, W. J. R. Matrangolo, Ivanildo Evódio Marriel

Publikováno v: Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA-Alice)
Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
instacron:EMBRAPA
Ciência Rural v.46 n.9 2016
Ciência Rural
Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
Ciência Rural, Iss 0 (2016)

Cratylia argentea is a leguminous shrub native to the cerrado, which has great potential for forage production and recovery of degraded areas. This study aimed to isolate, characterize, and select efficient rhizobial strains in symbiosis with Cratyli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8894c8b9ae30acaca8a795d00d95e779
https://doi.org/10.1590/0103-8478cr20151137